FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to a minibody for binding to a prostate-specific membrane agent (PSMA) comprising a scFv sequence that can bind to PSMA, said scFv comprising a variable heavy domain (VH) linked to a variable light domain (VL) by a linker sequence; an artificial hinge region and a human IgG CH3 sequence; and an isolated polynucleotide that encodes said minibody. Also disclosed is an anti-PSMA cys-diabody for use in the manufacture of a drug for cancer diagnosis. Invention also relates to a method for diagnosing cancer associated with the expression of PSMA in a subject, comprising administering an anti-PSMA minibody or an anti-PSMA cys-diabody. Also disclosed is a method of treating cancer associated with the expression of PSMA in a subject using said minibody or cys-diabody.
EFFECT: invention allows targeted delivery of human prostate-specific membrane antigen (PSMA) using high-efficiency minibodies and cys-diabodies, as well as the diagnosis and treatment of cancer associated with PSMA expression.
110 cl, 27 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
RECOVERED PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) ANTIBODY AND METHOD OF INHIBITION OF PSMA-EXPRESSING CELL GROWTH | 2006 |
|
RU2421466C2 |
RG1 ANTIBODIES AND APPLICATION THEREOF | 2004 |
|
RU2377252C2 |
ANTIBODIES AGAINST THE PROGRAMMED DEATH LIGAND (PD-L1) AND APPLICATION THEREOF | 2019 |
|
RU2761638C1 |
METHOD FOR GENERATING ACTIVE ANTIBODIES AGAINST RESISTANCE ANTIGEN, ANTIBODIES PRODUCED BY SAME METHOD AND USING THEM | 2007 |
|
RU2515904C2 |
NUCLEIC ACIDS ENCODING ANTIBODIES AGAINST SIALYLATED HUMAN LEWIS ANTIGEN | 2014 |
|
RU2791967C2 |
DIAGNOSING AND TREATING MALIGNANT TUMOUR WITH USING ANTI-EREG ANTIBODY | 2007 |
|
RU2537245C2 |
MODIFIED EXOTOXIN A PSEUDOMONADES | 2014 |
|
RU2687143C2 |
ANTIBODIES AGAINST VISTA AND APPLICATION THEREOF | 2018 |
|
RU2750723C1 |
ANTI-PD-1 ANTIBODIES | 2015 |
|
RU2711141C2 |
CELL DAMAGE INDUCING THERAPEUTIC MEDICINAL PRODUCT FOR ANTICANCER THERAPY | 2017 |
|
RU2746754C2 |
Authors
Dates
2018-12-03—Published
2010-12-02—Filed